PMID: 11921013Mar 29, 2002Paper

Approach to Hodgkin's lymphoma in the new millennium

Hematological Oncology
Henry C Fung, Auayporn P Nademanee

Abstract

Approximately 75% of patients with Hodgkin's lymphoma can be cured with modern chemotherapy and radiation. Most patients are treated according to clinical stage and the associated prognostic factors. For patients with limited stage Hodgkin's lymphoma, combined modality treatment has replaced subtotal nodal irradiation as the preferred treatment option. This approach eliminates laparotomy and potentially decreases the long-term toxicity secondary to extended field irradiation and splenectomy. Furthermore, recent studies suggest that it may improve disease control and possibly survival. Multiple novel regimens have been tested in the past 20 years in patients with advanced Hodgkin's lymphoma including dose-intense regimens, but current evidence suggests that ABVD remains the treatment of choice outside clinical trials. Over the past decade, the treatment-related morbidity and mortality associated with autologous stem cell transplantation have reduced significantly and stem cell transplant is becoming the treatment of choice for most patients with primary refractory or recurrent Hodgkin's lymphoma. With longer follow-up, long-term complications, in particular secondary malignancy have become the leading cause of late treatment fai...Continue Reading

References

Nov 19, 1992·The New England Journal of Medicine·G P CanellosB A Peterson
Jan 1, 1991·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G BonadonnaL Gianni
Feb 11, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D L LongoV T DeVita
Feb 1, 1991·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J Kagan, C M Croce
Apr 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M RoachR T Hoppe
Sep 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P Klimo, J M Connors
Nov 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T A ListerM Tubiana
Sep 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D L LongoV T DeVita
Sep 15, 1971·International Journal of Cancer. Journal International Du Cancer·P Correa, G T O'Conor
May 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N L BartlettS J Horning
Feb 1, 1996·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P J BiermanJ O Armitage
Jan 1, 1996·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D HasencleverV Diehl
Feb 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·V BonfanteG Bonadonna
Jun 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M LoefflerE W Schwarze
Nov 18, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D L LongoV T DeVita
Jan 24, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J H GlickM M Oken
Mar 21, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M LoefflerP Wiernik
Feb 2, 1999·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H H Grunicke
May 21, 1999·Bone Marrow Transplantation·P J Stiff
Mar 1, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S J HorningP Cassileth

❮ Previous
Next ❯

Citations

Dec 10, 2003·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Gary WarburtonJaime S Brahim
Sep 10, 2003·The Annals of Thoracic Surgery·Bahram KianiPatrick Ross
Oct 22, 2003·Otolaryngologic Clinics of North America·Laxmeesh M Nayak, Daniel G Deschler
Jan 23, 2004·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Pamela F RodeheaverDebra E Lyon
Jan 18, 2013·Leukemia & Lymphoma·Albert AltésMontserrat Baiget
Feb 11, 2019·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·A AmraeeL Darvish
May 21, 2013·American Journal of Hematology·Garrett C LoweJulia S Lehman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

© 2022 Meta ULC. All rights reserved